Phenotypic Profiles Among 72 Caucasian and Afro-Caribbean Patients with Antisynthetase Syndrome Involving Anti-PL7 or Anti-PL12 Autoantibodies
European Journal of Internal Medicine · 2023-09 · 115 · 104-113
DOI: 10.1016/j.ejim.2023.06.012 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Internal Medicine, 2023-09. Verfasst von Aurore Abel und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Martinique University Hospital, CEDEX CS, 90632 Fort-de-France, Martinique, France; Department of internal Medicine …. Hauptthemen laut MEDLINE: Autoantibodies, Myositis. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 69 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVES: Antisynthetase syndrome (ASyS) is a rare autoimmune disease. We aimed to determine clinical, biological, radiological, and evolutive profiles of ASyS patients with anti-PL7 or anti-PL12 autoantibodies. METHODS: We performed a retrospective study that included adults with overt positivity for anti-PL7/anti-PL12 autoantibodies and at least one Connors' criterion. RESULTS: Among 72 patients, 69% were women, 29 had anti-PL7 and 43 anti-PL12 autoantibodies, median age was 60.3 years, and median follow-up period was 52.2 months. At diagnosis, 76% of patients had interstitial lung disease, 61% had arthritis, 39% myositis, 25% Raynaud's phenomenon, 18% mechanic's hands, and 17% had fever. The most frequent pattern on initial chest computed tomography was non-specific interstitial pneumonia and 67% had fibrosis at last follow-up. During follow-up, 12 patients had pericardial effusion (18%), 19 had pulmonary hypertension (29%), 9 (12.5%) had neoplasms, and 14 (19%) died. Sixty-seven patients (93%) received at least one steroid or immunosuppressive drug. Patients with anti-PL12 autoantibodies were younger (p=0.01) and more frequently exhibited anti-SSA autoantibodies (p=0.01); patients with anti-PL7 autoantibodies had more severe weakness and higher maximum creatine kinase levels (p=0.03 and 0.04, respectively). Initial severe dyspnoea was more common in patients from the West Indies (p=0.009), with lower predicted values of forced vital capacity, forced expiratory volume in 1s, and total lung capacity (p=0.01, p=0.02, p=0.01, respectively) contributing to a more severe 'respiratory' initial presentation. CONCLUSIONS: The high mortality and significant numbers of cardiovascular events, neoplasms and lung fibrosis in anti-PL7/12 patients justify close monitoring and question addition of antifibrotic drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Martinique University Hospital, CEDEX CS, 90632 Fort-de-France, Martinique, France; Department of internal Medicine and Infectious Diseases Department, Haut Leveque Hospital, University…
- Department of internal Medicine and Infectious Diseases Department, Haut Leveque Hospital, University Hospital Centre of Bordeaux, F33604 Pessac, France; Université de Bordeaux, UMR CNRS 5164 Immunoconcept, F33000 Borde…
- Université de Bordeaux, UMR CNRS 5164 Immunoconcept, F33000 Bordeaux, France; CHU de Bordeaux, Laboratoire d'Immunologie et Immunogénétique, Hôpital Pellegrin, F33000 Bordeaux, France.
- Laboratoire d'immunologie, Cité Hospitalière de Mangot-Vulcin, CHU de Martinique.
- Department of Internal Medicine, Martinique University Hospital, CEDEX CS, 90632 Fort-de-France, Martinique, France.
- CHU de Bordeaux, Service de médecine interne et maladies infectieuses, Hôpital Saint-André, F33000 Bordeaux, France; University Bordeaux, ISPED, Inserm U1219, Bordeaux Population Health Research Center, teamGHIGS. F3300…
Zitieren
APA
Abel, A., Lazaro, E., Ralazamahaleo, M., Pierrisnard, E., Suzon, B., Bonnet, F., Mercié, P., Macey, J., Agossou, M., Viallard, J. F., Deligny, C., & Rivière, E. (2023). Phenotypic Profiles Among 72 Caucasian and Afro-Caribbean Patients with Antisynthetase Syndrome Involving Anti-PL7 or Anti-PL12 Autoantibodies. European Journal of Internal Medicine, 115, 104-113. https://doi.org/10.1016/j.ejim.2023.06.012
Vancouver
Abel A, Lazaro E, Ralazamahaleo M, Pierrisnard E, Suzon B, Bonnet F, et al. Phenotypic Profiles Among 72 Caucasian and Afro-Caribbean Patients with Antisynthetase Syndrome Involving Anti-PL7 or Anti-PL12 Autoantibodies. European Journal of Internal Medicine. 2023;115:104-113. doi:10.1016/j.ejim.2023.06.012
BibTeX
@article{Abel2023,
author = {Abel, Aurore and Lazaro, Estibaliz and Ralazamahaleo, Mamy and Pierrisnard, Emma and Suzon, Benoit and Bonnet, Fabrice and Mercié, Patrick and Macey, Julie and Agossou, Moustapha and Viallard, Jean-Francois and Deligny, Christophe and Rivière, Etienne},
title = {Phenotypic Profiles Among 72 Caucasian and Afro-Caribbean Patients with Antisynthetase Syndrome Involving Anti-PL7 or Anti-PL12 Autoantibodies},
journal = {European Journal of Internal Medicine},
year = {2023},
volume = {115},
pages = {104--113},
doi = {10.1016/j.ejim.2023.06.012}
}
EUVIMED